🚀 VC round data is live in beta, check it out!
Largest Medical Imaging & Diagnostics Public Companies
Benchmark revenue and EBITDA valuation multiples for public comps like
Agilent, GE HealthCare, Natera, Labcorp and Quest Diagnostics.
 | $121 | +12% | $34B | $36B | 5.0x | 17.3x | ||
| $74 | +5% | $34B | $40B | 1.9x | 10.7x | ||
| $208 | +38% | $29B | $29B | 11.8x | (109.9x) | ||
| $269 | +12% | $22B | $28B | 2.0x | 11.5x | ||
| $196 | +10% | $22B | $28B | 2.5x | 12.5x | ||
| $104 | +127% | $20B | $21B | — | — | ||
 | $17 | -13% | $14B | $13B | 6.2x | 37.6x | ||
 | $107 | -22% | $13B | $13B | 2.6x | 10.4x | ||
| $91 | +93% | $12B | $12B | 11.6x | (59.7x) | ||
 | $103 | -37% | $11B | $11B | 58.6x | 66.1x | ||
| $93 | 0% | $10B | $13B | 4.5x | 14.8x | ||
| $41 | -9% | $8B | $9B | 4.3x | 11.8x | ||
| $15 | -22% | $7B | $11B | 1.5x | 8.3x | ||
| $84 | -20% | $5B | $6B | 3.8x | 10.4x | ||
| $58 | +11% | $4B | $6B | 2.6x | 17.7x | ||
 | $74 | -36% | $4B | $4B | 3.2x | 9.7x | ||
| $11 | -45% | $4B | $4B | 4.6x | 81.3x | ||
| $31 | -- | $3B | $3B | 13.4x | (67.7x) | ||
| $33 | +10% | $3B | $2B | 4.3x | 15.9x | ||
 | $15 | +2% | $3B | $2B | 8.2x | 29.0x | ||
| $51 | +48% | $2B | $1B | 8.0x | (3.3x) | ||
 | $3 | +33% | $2B | $2B | 1.5x | 5.8x | ||
| $4 | -8% | $2B | $2B | 4.5x | 41.9x | ||
 | $3 | -22% | $2B | $2B | 3.8x | 13.6x | ||
 | $47 | +15% | $2B | $2B | 2.7x | 10.5x | ||
| $2 | -14% | $2B | $1B | — | — | ||
| $5 | +135% | $1B | $1B | 12.3x | (48.8x) | ||
| $2 | -22% | $1B | $1B | 1.8x | 18.3x | ||
| $12 | +4% | $1B | $6B | — | — | ||
| $1 | +6% | $1B | $1B | — | — | ||
| $3 | -13% | $1B | $1B | — | — | ||
| $8 | +29% | $1B | $1B | 1.8x | 28.0x | ||
 | $62 | +49% | $993M | $1B | 2.8x | 10.0x | ||
| $10 | -- | $927M | $2B | 1.8x | 7.9x | ||
| $7 | +48% | $900M | $630M | — | — | ||
| $24 | -13% | $835M | $834M | 5.4x | 12.3x | ||
| $1 | +95% | $826M | $2B | 1.1x | 5.0x | ||
 | $25 | -29% | $771M | $832M | — | — | ||
| $25 | +26% | $763M | $500M | 1.5x | 14.1x | ||
| $9 | +39% | $739M | $563M | — | — | ||
| $6 | +7% | $725M | $501M | — | — | ||
| $2 | -4% | $612M | $1B | 1.9x | 9.1x | ||
| $28 | +112% | $609M | $708M | 2.6x | 12.9x | ||
| $12 | +44% | $502M | $772M | 0.9x | 6.6x | ||
 | $1 | -7% | $324M | $298M | 4.5x | 13.1x | ||
| $30 | -23% | $314M | $362M | 2.2x | 6.6x | ||
| $1 | -33% | $280M | $489M | 0.9x | 3.5x | ||
| $0 | -63% | $277M | $911M | 0.9x | 4.9x | ||
| $3 | +6% | $263M | $550M | 3.1x | 18.8x | ||
| $1 | +4% | $221M | $267M | 42.4x | (5.0x) | ||
| $8 | -27% | $200M | $210M | — | — | ||
| $13 | +2% | $179M | $163M | — | — | ||
| $5 | -- | $169M | $169M | — | — | ||
 | $11 | -10% | $165M | $140M | 1.1x | 9.7x | ||
| $9 | -14% | $158M | $155M | 5.2x | 34.2x | ||
| $2 | +98% | $157M | $65M | 2.6x | — | ||
| $2 | -57% | $150M | $98M | 5.0x | — | ||
| $0 | +15% | $142M | $126M | 1.8x | 7.3x | ||
| $13 | +24% | $133M | $187M | 2.0x | (12.8x) | ||
| $1 | +79% | $128M | $93M | 6.0x | (2.8x) | ||
| $39 | -14% | $123M | $80M | 377.5x | (5.6x) | ||
| $19 | +50% | $118M | $105M | — | — | ||
 | $2 | +419% | $114M | $109M | — | (11.8x) | ||
| $2 | +27% | $113M | $171M | 1.5x | 358.3x | ||
| $5 | +15% | $110M | ($16M) | — | — | ||
| $1 | -44% | $96M | $206M | — | — | ||
| $18,551 | -22% | $94M | $78M | — | — | ||
 | $1 | -46% | $89M | $181M | 0.1x | 2.6x | ||
| $5 | +10% | $77M | $69M | — | (10.2x) | ||
| $0 | -37% | $73M | $66M | 10.4x | (5.5x) | ||
 | $5 | -4% | $73M | $64M | 3.1x | 14.4x | ||
| $3 | -52% | $72M | $65M | 1.0x | (7.2x) | ||
| $2 | -52% | $71M | $69M | 14.3x | (11.3x) | ||
| $3 | +38% | $67M | $73M | — | — | ||
| $1 | -35% | $66M | $66M | 2.9x | — | ||
| $0 | -1% | $63M | $65M | — | — | ||
| $3 | -39% | $61M | $50M | — | — | ||
| $0 | -10% | $50M | $38M | 1.7x | (134.8x) | ||
| $1 | -47% | $49M | $45M | 75.5x | (2.0x) | ||
 | $27 | -12% | $48M | $41M | — | — | ||
| $0 | -47% | $40M | $34M | — | — | ||
| $0 | -18% | $32M | $15M | 0.5x | (1.4x) | ||
| $0 | -40% | $28M | $22M | 1.7x | 9.0x | ||
| $2 | +7% | $22M | $13M | 0.7x | (7.9x) | ||
| $0 | -45% | $22M | $31M | 4.0x | (4.3x) | ||
 | $0 | +2% | $22M | $21M | — | — | ||
 | $1 | -4% | $21M | $19M | — | — | ||
| $1 | +10% | $20M | $20M | — | — | ||
| $1 | -36% | $19M | $80M | — | — | ||
| $0 | +7% | $16M | $8M | 38.8x | (0.8x) | ||
| $4 | -11% | $14M | $20M | — | — | ||
| $3 | -6% | $14M | $18M | 1.1x | 11.9x | ||
| $0 | -72% | $10M | $9M | 1.4x | (3.4x) | ||
| $7 | +14% | $10M | $8M | — | — | ||
| $0 | -16% | $5M | $4M | — | — | ||
| $4 | -47% | $5M | $5M | — | — | ||
| $0 | -61% | $5M | $3M | 1.5x | (4.9x) | ||
| $0 | +16% | $3M | $3M | — | — | ||
 | $0 | -- | $3M | $3M | — | — | ||
| $0 | -37% | $2M | $2M | — | — |
Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.